Cite
Preferences for first-line treatment of advanced urothelial carcinoma among US practicing oncologists and patients
MLA
Petros Grivas, et al. “Preferences for First-Line Treatment of Advanced Urothelial Carcinoma among US Practicing Oncologists and Patients.” Future Oncology, vol. 19, Feb. 2023, pp. 369–83. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........71c42b26aacddc3ab81459124c9d5fe2&authtype=sso&custid=ns315887.
APA
Petros Grivas, Phani Veeranki, Kevin Chiu, Vivek Pawar, Jane Chang, & Murtuza Bharmal. (2023). Preferences for first-line treatment of advanced urothelial carcinoma among US practicing oncologists and patients. Future Oncology, 19, 369–383.
Chicago
Petros Grivas, Phani Veeranki, Kevin Chiu, Vivek Pawar, Jane Chang, and Murtuza Bharmal. 2023. “Preferences for First-Line Treatment of Advanced Urothelial Carcinoma among US Practicing Oncologists and Patients.” Future Oncology 19 (February): 369–83. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........71c42b26aacddc3ab81459124c9d5fe2&authtype=sso&custid=ns315887.